10x Genomics, Inc.10x Genomics, Inc.10x Genomics, Inc.

10x Genomics, Inc.

No trades
See on Supercharts

TXG fundamentals

Key facts

Market capitalization
Founded
CEO
Website
About

10X Genomics, Inc. is a life science technology company, which engages in building products to interrogate, understand and master biology. Its integrated solutions include single cell transcriptomics, single cell genomics, single cell epigenomes, linked-reads genomics and spatial transcriptomics. The company’s products include Single Cell Gene Expression, Immune Profiling, ATAC, and Genome. The company was founded by Serge Saxonov, Ben Hindson and Kevin D. Ness on July 2, 2012 and is headquartered in Pleasanton, CA.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
TXG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company